Pre Transplantation Melanoma

Hospices Civils de Lyon37 enrolled

Overview

Melanoma incidence is increase in global population and number of transplantation also. However immunosuppressor increase recurrence risk of melanoma. There are more and more cases of eligible patients to transplant with an antecedent of melanoma. There is no guideline yet. Main objective is survival time without melanoma recurrence in this population to do guideline of time limit or not between melanoma and transplantation by stage.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Malignant Melanoma

Interventions

patient with melanoma pre transplantationOTHER

survival time without melanoma recurrence

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patient with an antecedent of melanoma before transplantation * Not opposite to participate Exclusion Criteria: * Under the age of 18 * patient under Guardianship * patient not affiliated with a health system

Locations (1)

service de dermatologie - hopital Edouard Herriot

Lyon, Rhone, France

Outcomes

Primary Outcomes

survival time without melanoma recurrence

Delay in recurrence-free survival since diagnosis and since transplantation

Time frame: at enrollment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.